Suppr超能文献

[内分泌干扰化学物质与致癌作用——乳腺癌、睾丸癌和前列腺癌]

[Endocrine disrupting chemicals and carcinogenesis--breast, testis and prostate cancer].

作者信息

Imaida K, Shirai T

机构信息

1st Department of Pathology, Nagoya City University Medical School.

出版信息

Nihon Rinsho. 2000 Dec;58(12):2527-32.

Abstract

Since exogenous hormones, including hormonal medicines such as diethylstilbestrol (DES), have been shown carcinogenic potentials in human and animals, it has been worried about whether endocrine disrupting chemicals(EDCs) have also carcinogenic potentials at their target organs, such as prostate, mammary gland, testes, uterus, ovary, thyroid, etc. In experimental animals, mammary tumors are induced by some pesticides, such as DDT and atrazine. Although testicular tumors are also induced by some EDCs, such as DES and E2, most of tumors are interstitial cell tumors, but not germ cell tumors, which are most common testicular tumors in man. Epidemiological studies showed that there is no EDC which clearly possess carcinogenic potentials in man, except dioxin and hormonal medicines.

摘要

由于外源性激素,包括己烯雌酚(DES)等激素类药物,已在人和动物身上显示出致癌潜力,人们一直担心内分泌干扰化学物质(EDCs)在其靶器官,如前列腺、乳腺、睾丸、子宫、卵巢、甲状腺等,是否也具有致癌潜力。在实验动物中,一些农药,如滴滴涕和阿特拉津,可诱发乳腺肿瘤。虽然一些EDCs,如DES和E2,也可诱发睾丸肿瘤,但大多数肿瘤是间质细胞瘤,而非人类最常见的睾丸肿瘤——生殖细胞瘤。流行病学研究表明,除二恶英和激素类药物外,没有哪种EDC在人类身上明确具有致癌潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验